SRPT:NASDAQ
Sarepta Therapeutics Inc
$22.02
arrow_upward
+5.16%(+1.08) 1D
$21.82
arrow_downward
-0.91% (-0.20)bedtimeAfter hours
Closed: Sep 9, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$20.80
High
$23.22
Low
$20.63
Mkt. cap
2.33B
Avg. vol.
3.17M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
Open
$20.80
High
$23.22
Low
$20.63
Mkt. cap
2.33B
Avg. vol.
3.17M
Volume
0.00
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.27
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
TipRanks
·
10 hours ago
Sarepta Therapeutics Rockets Back After Oversold Sell-Off
GuruFocus
·
13 hours ago
SRPT Looks 79.1% Undervalued on GF Value™ Despite Profitability Challenges
Seeking Alpha
·
14 hours ago
Sarepta Therapeutics climbs 10%, rebounding from recent slide (SRPT:NASDAQ)
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc